• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

USA Lawmakers OK $870M for Bird Flu Vaccine

Niko

Editor, Senior Moderator
Lawmakers OK $870M for Bird Flu Vaccine
Associated Press 03.22.07, 12:03 PM ET


The Department of Health and Human Services would get $870 million this year to fund vaccine development and prepare for a bird flu epidemic under a bill approved by the House Appropriations Committee.

The committee, chaired by David Obey, D-Wis., approved the bird flu funds by a 36-28 vote late last week as part of a supplemental fiscal 2007 spending bill for the Defense Department and other agencies.

In 2006, the government awarded more than $1 billion to drug companies to research and develop bird flu vaccines. In January this year, HHS awarded $132.5 million in bird flu program contracts to British drug maker GlaxoSmithKline (nyse: GSK - news - people ) PLC, Novartis (nyse: NVS - news - people ) AG and Iomai Corp. (nasdaq: IOMI - news - people )

Vote for the spending bill have yet to be scheduled. The bill must be approved by the full House and then the Senate before becoming law.

Lawmakers OK $870M for Bird Flu Vaccine
 
Back
Top